Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs PANACEA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE PANACEA BIOTECH TTK HEALTHCARE/
PANACEA BIOTECH
 
P/E (TTM) x 32.2 -60.9 - View Chart
P/BV x 2.2 0.9 249.6% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 TTK HEALTHCARE   PANACEA BIOTECH
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-23
PANACEA BIOTECH
Mar-23
TTK HEALTHCARE/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,106191 577.9%   
Low Rs668107 623.0%   
Sales per share (Unadj.) Rs513.275.1 683.4%  
Earnings per share (Unadj.) Rs31.6-5.5 -573.8%  
Cash flow per share (Unadj.) Rs40.70.9 4,632.5%  
Dividends per share (Unadj.) Rs10.000-  
Avg Dividend yield %1.10-  
Book value per share (Unadj.) Rs674.7137.7 489.9%  
Shares outstanding (eoy) m14.1361.25 23.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.72.0 86.9%   
Avg P/E ratio x28.0-27.1 -103.5%  
P/CF ratio (eoy) x21.8170.0 12.8%  
Price / Book Value ratio x1.31.1 121.3%  
Dividend payout %31.60-   
Avg Mkt Cap Rs m12,5299,142 137.1%   
No. of employees `000NANA-   
Total wages/salary Rs m1,2341,265 97.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m7,2514,599 157.7%  
Other income Rs m483517 93.6%   
Total revenues Rs m7,7345,116 151.2%   
Gross profit Rs m31347 666.7%  
Depreciation Rs m128391 32.7%   
Interest Rs m5244 118.1%   
Profit before tax Rs m616128 481.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m170466 36.5%   
Profit after tax Rs m447-337 -132.4%  
Gross profit margin %4.31.0 422.9%  
Effective tax rate %27.5363.5 7.6%   
Net profit margin %6.2-7.3 -84.0%  
BALANCE SHEET DATA
Current assets Rs m10,6645,623 189.6%   
Current liabilities Rs m2,1083,297 63.9%   
Net working cap to sales %118.050.6 233.3%  
Current ratio x5.11.7 296.7%  
Inventory Days Days1359 21.8%  
Debtors Days Days46448 972.2%  
Net fixed assets Rs m9947,028 14.1%   
Share capital Rs m14161 230.7%   
"Free" reserves Rs m9,3938,375 112.2%   
Net worth Rs m9,5348,436 113.0%   
Long term debt Rs m0202 0.0%   
Total assets Rs m11,65812,712 91.7%  
Interest coverage x12.83.9 328.5%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.4 171.9%   
Return on assets %4.3-2.3 -185.7%  
Return on equity %4.7-4.0 -117.1%  
Return on capital %7.02.0 351.4%  
Exports to sales %9.143.3 20.9%   
Imports to sales %1.424.4 5.8%   
Exports (fob) Rs m6571,992 33.0%   
Imports (cif) Rs m1021,124 9.1%   
Fx inflow Rs m6571,992 33.0%   
Fx outflow Rs m1631,191 13.7%   
Net fx Rs m494801 61.7%   
CASH FLOW
From Operations Rs m-261-4,225 6.2%  
From Investments Rs m3304,303 7.7%  
From Financial Activity Rs m-124-184 67.6%  
Net Cashflow Rs m-55-105 52.8%  

Share Holding

Indian Promoters % 74.6 73.6 101.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.0 1.0 524.2%  
FIIs % 0.0 0.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 25.4 26.4 96.3%  
Shareholders   16,651 47,091 35.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on TTK HEALTHCARE vs Panacea Biotech

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

TTK HEALTHCARE vs Panacea Biotech Share Price Performance

Period TTK HEALTHCARE Panacea Biotech S&P BSE HEALTHCARE
1-Day 0.61% -1.74% 1.18%
1-Month 0.52% -20.01% -0.75%
1-Year 40.65% 11.75% 61.82%
3-Year CAGR 44.33% -12.26% 18.16%
5-Year CAGR 16.84% -9.98% 19.79%

* Compound Annual Growth Rate

Here are more details on the TTK HEALTHCARE share price and the Panacea Biotech share price.

Moving on to shareholding structures...

The promoters of TTK HEALTHCARE hold a 74.6% stake in the company. In case of Panacea Biotech the stake stands at 73.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of TTK HEALTHCARE and the shareholding pattern of Panacea Biotech.

Finally, a word on dividends...

In the most recent financial year, TTK HEALTHCARE paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 31.6%.

Panacea Biotech paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of TTK HEALTHCARE, and the dividend history of Panacea Biotech.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.